BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 37559511)

  • 1. Poststroke Depression: An Update.
    Robinson RG; Jorge RE; Starkstein SE
    J Neuropsychiatry Clin Neurosci; 2024; 36(1):22-35. PubMed ID: 37559511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Post-Stroke Depression: A Review.
    Robinson RG; Jorge RE
    Am J Psychiatry; 2016 Mar; 173(3):221-31. PubMed ID: 26684921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical significance and possibilities of therapy of post-stroke depression].
    Trusova NA; Levin OS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2019; 119(9. Vyp. 2):60-67. PubMed ID: 31825392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterocyclics and selective serotonin reuptake inhibitors in the treatment and prevention of poststroke depression.
    Bhogal SK; Teasell R; Foley N; Speechley M
    J Am Geriatr Soc; 2005 Jun; 53(6):1051-7. PubMed ID: 15935033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mortality and poststroke depression: a placebo-controlled trial of antidepressants.
    Jorge RE; Robinson RG; Arndt S; Starkstein S
    Am J Psychiatry; 2003 Oct; 160(10):1823-9. PubMed ID: 14514497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The psychopharmacology of brain vascular disease/poststroke depression.
    Jones M; Corcoran A; Jorge RE
    Handb Clin Neurol; 2019; 165():229-241. PubMed ID: 31727214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative efficacy and acceptability of antidepressant treatment in poststroke depression: a multiple-treatments meta-analysis.
    Sun Y; Liang Y; Jiao Y; Lin J; Qu H; Xu J; Zhao C
    BMJ Open; 2017 Aug; 7(8):e016499. PubMed ID: 28775189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is Electroacupuncture an Effective and Safe Treatment for Poststroke Depression? An Updated Systematic Review and Meta-Analysis.
    Wang X; Cai W; Wang Y; Huang S; Zhang Q; Wang F
    Biomed Res Int; 2021; 2021():8661162. PubMed ID: 34485527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Post-stroke depression: an update.
    Espárrago Llorca G; Castilla-Guerra L; Fernández Moreno MC; Ruiz Doblado S; Jiménez Hernández MD
    Neurologia; 2015; 30(1):23-31. PubMed ID: 22901370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is it safe to use antidepressants after a stroke?
    Rampello L; Battaglia G; Raffaele R; Vecchio I; Alvano A
    Expert Opin Drug Saf; 2005 Sep; 4(5):885-97. PubMed ID: 16111451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antidepressants for the treatment of depression in people with cancer.
    Ostuzzi G; Matcham F; Dauchy S; Barbui C; Hotopf M
    Cochrane Database Syst Rev; 2018 Apr; 4(4):CD011006. PubMed ID: 29683474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of poststroke depression: does prophylactic pharmacotherapy work?
    Salter KL; Foley NC; Zhu L; Jutai JW; Teasell RW
    J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):1243-51. PubMed ID: 22554569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antidepressants for people with epilepsy and depression.
    Maguire MJ; Marson AG; Nevitt SJ
    Cochrane Database Syst Rev; 2021 Apr; 4(4):CD010682. PubMed ID: 33860531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and Safety of Citalopram for the Treatment of Poststroke Depression: A Meta-Analysis.
    Cui M; Huang CY; Wang F
    J Stroke Cerebrovasc Dis; 2018 Nov; 27(11):2905-2918. PubMed ID: 30201459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in antidepressants for treating post-stroke depression.
    Paolucci S
    Expert Opin Pharmacother; 2017 Jul; 18(10):1011-1017. PubMed ID: 28535081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Notable efficacy of Shugan Jieyu capsule in treating adult with post-stroke depression: A PRISMA-compliant meta-analysis of randomized controlled trials.
    Wu T; Yue T; Yang P; Jia Y
    J Ethnopharmacol; 2022 Aug; 294():115367. PubMed ID: 35562090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of Sihogayonggolmoryeo-tang (Saikokaryukotsuboreito, Chai-Hu-Jia-Long-Gu-Mu-Li-Tang) for post-stroke depression: A systematic review and meta-analysis.
    Kwon CY; Lee B; Chung SY; Kim JW; Shin A; Choi YY; Yun Y; Leem J
    Sci Rep; 2019 Oct; 9(1):14536. PubMed ID: 31601868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of Paroxetine for Poststroke Depression: A Meta-Analysis.
    Li L; Han Z; Li L; Han L; Yan B
    J Stroke Cerebrovasc Dis; 2020 May; 29(5):104664. PubMed ID: 32093988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological management of post-stroke depression: an update of the evidence and clinical guidance.
    Mortensen JK; Andersen G
    Expert Opin Pharmacother; 2021 Jun; 22(9):1157-1166. PubMed ID: 33530765
    [No Abstract]   [Full Text] [Related]  

  • 20. Antidepressants for the treatment of depression in people with cancer.
    Ostuzzi G; Matcham F; Dauchy S; Barbui C; Hotopf M
    Cochrane Database Syst Rev; 2015 Jun; 2015(6):CD011006. PubMed ID: 26029972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.